Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6. 1994

H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
Institute for Immunology, University of Munich, Germany.

The human Mono Mac 6 cell line exhibits many characteristics of mature blood monocytes including expression of the CD14 molecule and production of cytokines, such as interleukin-1 (IL-1), IL-6, and tumor necrosis factor. To determine whether these cells can be further differentiated, we treated the cells for up to 3 days with either prostaglandin E2 (PGE2; 10(-5) or 10(-6) M), lipopolysaccharide (LPS; 10-20 ng/ml), or tetradecanoylphorbol-13-acetate (TPA; 10-50 ng/ml). All three reagents reduced proliferation and expression of the early myelomonocytic antigen CD33, and all increased phagocytosis of staphylococci and constitutive expression of mRNA for the macrophage colony-stimulating factor (M-CSF) receptor. By contrast, with respect to CD23 (Fc epsilon RII) expression, CD14 expression, and production of O2-, the three reagents induced distinct responses. Expression of CD23 (Fc epsilon RII) on Mono Mac 6 cells (36%) was not increased by LPS and TPA but was increased by PGE2 treatment to 48%, with a 50% increase of fluorescence intensity. The CD14 antibody My4 stained more than 75% of untreated Mono Mac 6 cells with a specific mean fluorescence intensity of 87.5 channels. This staining was increased more than twofold by both PGE2 and LPS. Staining with the CD14 antibody UCHM1 (6%) was increased to 43% by PGE2 and to 43% by LPS. This increase in CD14 cell surface expression was accompanied by a rise in soluble CD14 and enhancement of CD14 mRNA. By contrast, TPA treatment resulted in a twofold decrease of CD14 cell surface staining with no significant change in sCD14, while CD14 mRNA was transiently down-regulated. Secretion of O2- (stimulated by TPA) was already detectable in untreated Mono Mac 6 cells (6.1 mmol/10(6) cells/30 min), and this response was enhanced 10-fold by pretreatment with LPS but not with PGE2 or TPA. The kinetics of M-CSF receptor mRNA, CD14 expression, and O2- production revealed that these monocytic features started to increase at 6-24 h and were maximal at 2 days. These data suggest that the three reagents induce maturation of the Mono Mac 6 cells to different levels or into different branches of the monocyte system with the notable differences that PGE2 enhances CD23 expression, LPS enhances O2- secretion, and TPA down-regulates CD14.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
February 1995, Atherosclerosis,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
September 1996, Antimicrobial agents and chemotherapy,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
April 1997, Leukemia research,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
June 1997, Journal of pharmacological and toxicological methods,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
July 1993, Immunobiology,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
December 1995, Cell biochemistry and function,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
November 1991, Journal of immunological methods,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
March 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
October 1993, Scandinavian journal of immunology,
H W Ziegler-Heitbrock, and W Schraut, and P Wendelgass, and M Ströbel, and T Sternsdorf, and C Weber, and M Aepfelbacher, and M Ehlers, and C Schütt, and J G Haas
January 2003, BioTechniques,
Copied contents to your clipboard!